YI - רווח למניה בשנים עשר החודשים האחרונים 111, Inc.

111, Inc. is expanding B2B pharmaceutical distribution in China while facing severe margin pressure. This chart on GURU.Markets illustrates the 12-month YoY earnings per share growth rate, where the value has settled at -44.70. The tech giant's success relies on the vertical integration of e-health services and logistics optimization via third-party cloud providers.

This indicator is calculated as the percentage change in net income per share over the last twelve months relative to the same period last year, which filters out short-term noise to reveal the actual business scaling vector. Analyzing the rolling year-over-year EPS growth chart helps determine whether 111, Inc. (YI) is capable of generating profit amidst aggressive pressure from the largest Chinese IT ecosystems.